The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials

被引:20
作者
Gruner, Laura F. [1 ,2 ]
Amitay, Efrat L. [1 ]
Heisser, Thomas [1 ,2 ]
Guo, Feng [1 ]
Niedermaier, Tobias [1 ]
Gies, Anton [3 ,4 ]
Hoffmeister, Michael [1 ]
Brenner, Hermann [1 ,3 ,4 ,5 ]
机构
[1] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Med Fac Heidelberg, D-69120 Heidelberg, Germany
[3] German Canc Res Ctr, Div Prevent Oncol, D-69120 Heidelberg, Germany
[4] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany
[5] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany
关键词
colorectal cancer; early detection; screening; fecal occult blood tests; invitation; IMMUNOCHEMICAL TESTS; INCREASING PARTICIPATION; POPULATION; PROGRAM; IMPLEMENTATION; INTERVENTIONS; STRATEGIES; ADHERENCE; OUTREACH; LEAFLET;
D O I
10.3390/cancers13071520
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary There is large heterogeneity in invitation schemes and participation rates in colorectal cancer screening programs offering fecal occult blood tests (nowadays mostly fecal immunochemical tests). It is unclear what the most effective invitation strategies are for fecal occult blood tests. In this systematic review, advance notification, mailed fecal occult blood test, and reminders had major, consistent, and complementary potential to increase participation in fecal occult blood test-based colorectal cancer screening. Our findings show that the effectiveness of invitations for fecal occult blood test-based colorectal cancer screening can be substantially increased across several settings by the implementation of comprehensive invitation strategies. Personal invitations for fecal occult blood tests (nowadays mostly fecal immunochemical tests) are increasingly used to raise their usage for colorectal cancer screening. However, there is a large heterogeneity in applied invitation schemes. We aimed to review evidence for the effectiveness of various invitation schemes. The main outcome was the fecal occult blood test usage rate. A systematic search was performed in Medline and Web of Science (up to 9 July 2020). Randomized controlled trials or cluster-randomized controlled trials were eligible, which reported on general invitations for fecal occult blood test-based colorectal cancer screening sent to the general population at average colorectal cancer risk. (PROSPERO 2020 CRD42020169409). Overall, 34 studies were included. Invitations with an attached, i.e., mailed fecal occult blood test consistently increased test usage by 4-19.7% points, compared to other methods of test provision. Likewise, the introduction of advance notification consistently led to a higher usage rate, with an increase of 3.3-10.8% points. Reminders showed positive but varying effects by method. With an increase of 8.5-15.8% points, letter or email reminders were more effective than reminders by phone call or text message (0.6-6.5% points). Inconsistent results were found for financial incentives ((-8.4)-20% points) and for added or changed invitation material ((-3.5)-11.8% points). With 3.5-24.7% points, the strongest increases in use were achieved by multifaceted invitation, implementing multiple components. Any invitation scheme was superior over no invitation. Advance notification, mailing of fecal occult blood test, and reminders were consistently shown to have major, complementary potential to increase participation in fecal occult blood test-based colorectal cancer screening settings.
引用
收藏
页数:14
相关论文
共 60 条
[51]   Effectiveness of a brief phone intervention to increase participation in a population-based colorectal cancer screening programme: a randomized controlled trial [J].
Selva, A. ;
Tora, N. ;
Pascual, E. ;
Espinas, J. A. ;
Bare, M. .
COLORECTAL DISEASE, 2019, 21 (10) :1120-1129
[52]   Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report [J].
Senore, Carlo ;
Basu, Partha ;
Anttila, Ahti ;
Ponti, Antonio ;
Tomatis, Mariano ;
Vale, Diama Bhadra ;
Ronco, Gugliemo ;
Soerjomataram, Isabelle ;
Primic-Zakelj, Maja ;
Riggi, Emilia ;
Dillner, Joakim ;
Elfstrom, Miriam Klara ;
Lonnberg, Stefan ;
Sankaranarayanan, Rengaswamy ;
Segnan, Nereo .
GUT, 2019, 68 (07) :1232-1244
[53]   Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter [J].
Senore, Carlo ;
Ederle, Andrea ;
DePretis, Giovanni ;
Magnani, Corrado ;
Canuti, Debora ;
Deandrea, Silvia ;
Zorzi, Manuel ;
Barca, Alessandra ;
Bestagini, Piero ;
Faitini, Katia ;
Bisanti, Luigi ;
Casale, Coralba ;
Ferro, Antonio ;
GiorgiRossi, Paolo ;
Quadrino, Francesco ;
Fiorina, Giorgia ;
Capuano, Arianna ;
Segnan, Nereo ;
Fantin, Alberto .
PREVENTIVE MEDICINE, 2015, 73 :106-111
[54]   Long-Term Mortality after Screening for Colorectal Cancer [J].
Shaukat, Aasma ;
Mongin, Steven J. ;
Geisser, Mindy S. ;
Lederle, Frank A. ;
Bond, John H. ;
Mandel, Jack S. ;
Church, Timothy R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (12) :1106-1114
[55]   Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial [J].
Somsouk, Ma ;
Rachocki, Carly ;
Mannalithara, Ajitha ;
Garcia, Dianne ;
Laleau, Victoria ;
Grimes, Barbara ;
Issaka, Rachel B. ;
Chen, Ellen ;
Vittinghoff, Eric ;
Shapiro, Jean A. ;
Ladabaum, Uri .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (03) :305-313
[56]   RoB 2: a revised tool for assessing risk of bias in randomised trials [J].
Sterne, Jonathan A. C. ;
Savovic, Jelena ;
Page, Matthew J. ;
Elbers, Roy G. ;
Blencowe, Natalie S. ;
Boutron, Isabelle ;
Cates, Christopher J. ;
Cheng, Hung-Yuan ;
Corbett, Mark S. ;
Eldridge, Sandra M. ;
Emberson, Jonathan R. ;
Hernan, Miguel A. ;
Hopewell, Sally ;
Hrobjartsson, Asbjorn ;
Junqueira, Daniela R. ;
Juni, Peter ;
Kirkham, Jamie J. ;
Lasserson, Toby ;
Li, Tianjing ;
McAleenan, Alexandra ;
Reeves, Barnaby C. ;
Shepperd, Sasha ;
Shrier, Ian ;
Stewart, Lesley A. ;
Tilling, Kate ;
White, Ian R. ;
Whiting, Penny F. ;
Higgins, Julian P. T. .
BMJ-BRITISH MEDICAL JOURNAL, 2019, 366
[57]   Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels [J].
Toes-Zoutendijk, Esther ;
van Leerdam, Monique E. ;
Dekker, Evelien ;
van Hees, Frank ;
Penning, Corine ;
Nagtegaal, Iris ;
van der Meulen, Miriam P. ;
van Vuuren, Anneke J. ;
Kuipers, Ernst J. ;
Bonfrer, Johannes M. G. ;
Biermann, Katharina ;
Thomeer, Maarten G. J. ;
van Veldhuizen, Harriet ;
Kroep, Sonja ;
van Ballegooijen, Marjolein ;
Meijer, Gerrit A. ;
de Koning, Harry J. ;
Spaander, Manon C. W. ;
Lansdorp-Vogelaar, Iris .
GASTROENTEROLOGY, 2017, 152 (04) :767-+
[58]   Invitation strategies and coverage in the population-based cancer screening programmes in the European Union [J].
Vale, Diama B. ;
Anttila, Ahti ;
Ponti, Antonio ;
Senore, Carlo ;
Sankaranaryanan, Rengaswamy ;
Ronco, Guglielmo ;
Segnan, Nereo ;
Tomatis, Mariano ;
Zakelj, Maja P. ;
Elfstrom, Klara M. ;
Lonnberg, Stefan ;
Dinner, Joakim ;
Basu, Partha .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2019, 28 (02) :131-140
[59]   Advance notification letters increase adherence in colorectal cancer screening: A population-based randomized trial [J].
van Roan, A. H. C. ;
Hal, L. ;
Wilschut, J. A. ;
Reijerink, J. C. I. Y. ;
van Vuuren, A. J. ;
van Ballegooijen, M. ;
Habbema, J. D. F. ;
van Leerdam, M. E. ;
Kuipers, Ernst J. .
PREVENTIVE MEDICINE, 2011, 52 (06) :448-451
[60]  
Vinker S, 2002, ISRAEL MED ASSOC J, V4, P424